Premiums Rose 2.9 Percent for ObamaCare Silver Plans

The price of ObamaCare silver plans increased an average of 2.9 percent nationally, according to a new report by the Urban Institute.

The new data, which were collected on silver plans from every state over the last year, ease widespread concerns that ObamaCare was fueling massive premium hikes.

Still, the researchers warn the future of premium increases is uncertain in the long-term. For plan’s prices to remain low, insurance companies must continue to feel pressure from customers to be competitive.

“Without plan switching, competitive pressures on insurers will weaken,” the report states.

Researchers found that insurers kept rates low by “developing more limited provider networks” – which means some providers accepted lower reimbursement rates.

“Whether these arrangements are sustainable and remain attractive to consumers over time is unknown,” the report states.

Premium increases varied greatly by region. Customers in the Northeast saw an increase of 1.8 percent compared to a high of 5.4 percent in the South.

Still, premiums remain the highest in the Northeast, where customers face an average of $284 per month. Customers in the South and Midwest pay about $50 less per month.

Source Link

Recommended Articles

White House Leaves One Trump-Era Policy Alone

The Biden administration has gutted many of former President Donald Trump’s health care policies, but there’s one that the White House has yet to touch, Kelly reports. It’s a 2019 rule that expanded individual coverage health reimbursement arrangements, or ICHRAs, which allowed employers to provide tax-exempt subsidies to help workers purchase Obamacare plans. The Biden administration’s ...

Read More

Court Strikes Down HHS Rule that Allowed Insurers to Not Count Copay Assistance

In a major victory for patients who depend on prescription drugs, Judge John D. Bates of the U.S. District Court for the District of Columbia struck down a Trump administration federal rule that allowed health insurers to not count drug manufacturer copay assistance towards a beneficiary’s out-of-pocket costs. The case was brought against the U.S. Department of Health and ...

Read More

Lawmakers, Payers And Providers All Air Grievances With Federal No Surprises Act Implementation

Amid a flurry of partisan roadblocks rolling out across Capitol Hill, representatives on both sides of the aisle came together Tuesday to critique federal agencies’ rollout of the No Surprises Act and throw their support behind court-ordered rewrites of independent dispute resolution (IDR) regulations. During a hearing exploring the “flawed implementation” of the law intended ...

Read More

As Biden Plans To Ban Medical Debt From Credit Scores, Advocates Press For More Change

The dramatic impact of medical debt on credit scores may soon be a thing of the past. On Thursday, the White House announced a plan outlined by the Consumer Financial Protection Bureau (CFPB) to eliminate medical debt from credit reports. The move — which follows an earlier decision from the three main credit bureaus to eliminate paid medical debt, medical ...

Read More